PubMed Health⌕ Search

Biomedical subjects

G Attali

Publications and source records attributed to G Attali.

3 recordsLinked to original sources

Complement and apoptosis.

Apoptosis and necrosis are two forms of cell death characterized by distinct morphologies. Until recently, complement-mediated cell lysis has been presented as a classical example of necrotic cell death. However, recent reports on apoptogenic effects of complement have shaken this dogma. The field has become even more confusing with descriptions of anti-apoptotic effects of complement. Necrosis has been associated traditionally with inflammation, whereas apoptosis has been regarded as noninflammatory. Therefore, first descriptions of the capacity of the complement system to identify apoptotic cells and to be activated by them, led to the development of the concept that complement opsonizes apoptotic cells for fast clearance by phagocytic cells. In the absence of such opsonization, (eg in C1q or C4 deficiency), apoptotic cells may remain longer in the body and may stimulate autoantibody production or undergo pro-inflammatory secondary necrosis. This has been associated in man and mouse with the development of an autoimmune disease like systemic lupus erythematosus. However, complement may also interfere with the programmed intention of apoptosis to avoid triggering of inflammation. Our recent results show that, under specific conditions, early apoptotic cells are not only opsonized by complement but may also be lysed, raising the possibility that under certain conditions apoptosis will be associated with an inflammatory reaction. The review describes and discusses the reports covering the various aspects of the interface between complement and apoptosis and its possible relevance to autoimmune diseases and inflammation and raises the following questions: 1. Can activated complement proteins induce apoptotic cell death? 2. Can complement protect cells from apoptosis? 3. Do apoptotic cells activate complement? and 4. What role is complement playing in clearance of apoptotic cells and which complement receptors are involved? Clearly, this research field is highly complex and still at its formation stage, yet interesting and important mechanisms are bound to emerge from these studies.

Apoptosis↗

Suppression of serum gonadal steroids in rats by chronic treatment with dopamine and serotonin reuptake inhibitors.

The impact of chronic administration (3 weeks) of dopamine and serotonin reuptake inhibitors on serum gonadal steroid hormones and prolactin was studied in intact male and female rats. Both the dopamine and the serotonin reuptake inhibitors lowered serum estradiol and progesterone levels in the female rats. The dopamine transporter blockers suppressed testosterone serum levels in the male rats, whereas serotonin reuptake inhibitors induced only a non-significant reduction (30%) of this hormone. In contrast to the decrease in gonadal steroids, none of the serotonin or the dopamine reuptake blockers altered prolactin serum levels in either the male or female rats. It seems that the effect of these agents on ovarian and testicular hormones is related to the impact of the monoamine reuptake inhibitors on the hypothalamic-pituitary-gonadal axis.

Animals↗

Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters.

The present study was designed to investigate the modulatory effect of gonadal steroids on brain dopamine (DA) and serotonin (5-HT) presynaptic transporters in female and male rats. Female and male rats were castrated and treated with either vehicle or gonadal hormones. The pharmacodynamic characteristics of the DA and 5-HT transporters were analyzed by [3H]BTCP and [3H]imipramine binding respectively. Ovariectomy (OVX) resulted in an upregulation of the striatal DA transporter and this alteration was prevented by estradiol (E2) or E2 + progesterone (P) treatment but not by P alone. In contrast to the DA transporter, the hypothalamic 5-HT transporter was down-regulated by OVX in female rats and this decrease was reversed by the administration of E2, P or their combination. The striatal DA transporter and the hypothalamic 5-HT transporter in male rat were not affected by orchidectomy or by administration of testicular hormone. Our findings indicate that ovarian, but not testicular, steroid hormones may play an important role in the regulation of brain DA and 5-HT transporters. It appears that ovarian hormones modulate rat brain 5-HT and DA transporters in opposite directions. These interactions between ovarian steroids and presynaptic transporters may be relevant to DA- and 5-HT-related neuropsychiatric disorders.

Animals↗